LAS VEGAS, June 7, 2022 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that a patent was issued that covers a method of improving nerve function using JAN101.
This prestigious award, sponsored by the American Heart Association’s Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB Council), recognizes investigators in the formative years of their faculty careers who have the potential to become future leaders in cardiovascular research.
KTBS3 - LSUHS and BRF’s Center for Molecular Imaging and Therapy are partnering to bring a national Alzheimer’s disease study to the area. The study is for patients with mild cognitive impairment and dementia with a focus on minority populations in underserved areas.
The Biomechanics Lab compares different surgical techniques side-by-side, with the goal of getting people back to work and athletes back to sport sooner. Dr. Giovanni Solitro, lab director, shares, “What I really love about this work is that it allows us to be protagonists. We can bring more innovation to the patient.”
Louisiana Senator Bill Cassidy was instrumental in the receipt of this funding for LSUHS, which will enhance the impact of the Center for Emerging Viral Threats (CEVT) as it is able to expand significantly in the new Center for Medical Education building. Additional medical education and research opportunities will yield enhanced economic impact to the region and the state.
Aaron Sheppard, a second-year medical student at the LSU Health Shreveport School of Medicine, has been selected to participate in the 2022-2023 class of the National Institutes of Health (NIH) Medical Research Scholars Program (MRSP).
LSU - J. Steven Alexander, PhD, Professor of Molecular and Cellular Physiology at LSU Health Shreveport, didn’t expect his biggest innovation to come from a nuisance he’d experienced once or twice during an otherwise nice swim.
Shreveport Times - LSUHS faculty published an article in the Journal of the AAOS, which is being used by institutions around the country for guidelines on elective and urgent surgical selection for orthopaedics during the COVID-19 pandemic.
41NBC - Mercer University School of Medicine, in partnership with the Department of Biomedical Sciences and LSU Health Shreveport, was recently awarded a $25,000 grant from the Rockefeller Foundation. The money will help to guide Covid-19 research about possible variants of the virus.
LSU Office of Research - While almost all research on addiction to stimulants (such as meth and cocaine) remains focused on dopamine and the body’s pleasure-and-reward system, a researcher at LSU Health Shreveport, Nicholas Goeders, took a different approach. Instead of reward, he looked at stress.
Ellen Friday, PhD, Clinical Assistant Professor and Researcher at LSUHS, is among the first 100 people globally to pass the QBRS exam and receive this credential, a distinction among biorepository science professionals.
J. Steven Alexander, PhD, Professor of Molecular and Cellular Physiology at LSU Health Shreveport, and his company, Arganum Transplant Solutions, was named the winner of Startup Prize 2021: Focus on Health. Arganum Transplant Solutions aims to transform the organ preservation market.
Shreveport Times - Research Notebook: Since the earliest days of the COVID-19 pandemic scientists around the world have been working together on critical genomic sequencing efforts to better understand how the SARS-CoV-2 virus spreads and evolves and help guide and evaluate public health response.
Bloomberg - While the U.S. is sequencing a much higher percentage of Covid samples than earlier, the bigger issue may be that not enough virus testing is done in the first place, said Jeremy Kamil, a virologist at Louisiana State University Health Shreveport.
A new variant of COVID-19 has been identified in Louisiana by scientists at the LSU Health Shreveport Emerging Viral Threats Center. LSUHS announced this month that the B.1.630 variant had been sequenced and reported by the center, though health officials believe this variant's predominance is very low and much less transmissable than the deadly delta variant.